Font Size: a A A
Keyword [Angiotensin receptor]
Result: 61 - 80 | Page: 4 of 5
61. Receptor Expression,Gene Polymorphism In Renin-angiotensin System(RAS) And The Efficacy Evaluation Of RAS Inhibitor(ACEI/ARB) In IgA Nephropathy
62. Effects And Mechanisms Of Angiotensin Receptor-Neprilysin Dual Inhibition On Cardiorenal Syndrome Via Regulating TGF-?/Smad Signaling Pathway
63. The Underlying Mechanisms Of Angiotensin Receptor-neprilysin Inhibitor Improve Heart Failure With Preserved Ejection Fracion Via IL-1?/mitochondrial Oxidative Stress
64. Efficacy Of Evening Medication Of Valsartan On Blood Pressure And Renal Function In Patients With Abnormal Nocturnal Blood Pressure
65. Clinical Research Progress Of Angiotensin Receptor Blocker In Cardiovascular Disease
66. Prognostic Factors Of Idiopathic Membranous Nephropathy Treated With ACEI/ARB Alone
67. The Maternal/Fetal RAS Gene-gene/environment Interactions In Preeclampsia:A Hybrid Study
68. Effects Of Estrogen On Vascular Function And Renin Angiotensin System Components In Renovascular Hypertension Rats
69. Comparative Effectiveness Of Different Renin-Angiotensin System Blockers In Patients With Prior Stroke:a PRISMA-Compliant Network Meta-Analysis
70. Clinical Analysis And Literature Review Of A Case Of Severe Heart Failure Treated With Sacubitril/Valsartan
71. Expression Of Renal Biopsy Tissue Angiotensin Receptor Of Patients With Malignant Hypertension
72. Application Acoustic Imaging Evaluation Of Angiotensin Receptor Blockers For DCM Left Ventricular Cavity Hemodynamic Effects
73. The Preventive Effect And Mechanism Of Angiotensin Receptor Neprilysin Inhibitor On Heart And Blood Vessels In A Rat Model Of Heart Failure With Preserved Ejection Fraction
74. Effects Of Angiotensin Receptor Neprilysin Inhibitor On Myocardial Protection After Myocardial Infarction In Rats
75. Application Of Network Meta Analysis Model To Study Angiotensin Receptor Antagonist Primary Prevention Of Ischemic Stroke
76. Angiotensin Receptor-Neprilysin Inhibitor In The Treatment Of Heart Failure
77. Safety And Efficacy Of Angiotensin Receptor-neprilysin Inhibitor In Non-dialysis Chronic Kidney Disease Patients Coexisting With Hypertension And Heart Failure With Reduced Ejection Fraction
78. Assessment Of Efficacy About Angiotensin Receptor-neprilysin Inhibitors On Ventricular Remodeling And Improvement Of Cardiac Function In Patients Concerning Chronic Heart Failure With Reduced Ejection Fraction
79. Efficacy Of Angiotensin Receptor-neprilysin Inhibitor In Patients With Chronic Heart Failure
80. Short-term Efficacy Observation Of Sacubitril/valsartan And ACEI/ARB In Patients With Dilated Cardiomyopathy And Heart Failure
  <<First  <Prev  Next>  Last>>  Jump to